Real-World Outcomes of Ambulatory Drug-Susceptible Tuberculosis Management During the COVID-19 Pandemic in Romania
Background: Romania continues to experience one of the highest tuberculosis (TB) burdens in the European Union/European Economic Area. During the COVID-19 pandemic, reduced inpatient capacity accelerated the use of ambulatory care for patients with drug-susceptible tuberculosis (DS-TB). This study evaluated treatment o...